Delivery Order SPE2DB20D3303-SPE2DB24FA2WE

Award Date 9/6/24
Potential Completion Date 9/27/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a firm fixed price of $7,322.67 and a completion date of September 17, 2024. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a...
The Defense Logistics Agency (DLA) awarded a $14,645.34 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to supply 4565827989 IMBRUVICA 420 MG TABLET 28S. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen,...
This is a $33,865.10 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,188,793 units of the drug Imbruvica 420 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through May 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,151.52 firm fixed-price contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $30,303.04 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the delivery of 420 mg IMBRUVICA tablets in 28-count packages. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a $21,968.01 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is to provide the medication IMBRUVICA 420 MG TABLET 28S, with a completion date of September 3, 2024. This represents a task order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen to supply a comprehensive range of pharmaceutical and medical products to support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,645.34 firm fixed price delivery order is for the supply of IMBRUVICA 280 MG TABLET 28S, a prescription medication, with a period of performance through August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product IMBRUVICA 140 MG TABLET 28S. The contract, valued at $7,322.67, has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order worth $7,322.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price and a delivery order contract type, with a period of performance ending on September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support federal healthcare programs and initiatives. The contract is not set aside and is part of a...
The U.S. government awarded a $7,322.67 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 280 MG TABLET 28S. This contract is a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a range of pharmaceutical products and...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2WE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $14,645.34 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,708,521 units of the medication IMBRUVICA 420 MG TABLET 28S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a period of performance through September 27, 2024 and does not utilize any set-aside designations.

Generated 12/6/24, 9:09 AM